share_log

科源制药(301281.SZ):拟对力诺制药增资合计2亿元

Keyuan Pharmaceutical (301281.SZ): Plans to increase Linuo Pharmaceutical's capital by a total of 200 million yuan

Gelonghui Finance ·  Jan 5 03:08

Gelonghui, January 5, 丨 Keyuan Pharmaceutical (301281.SZ) announced that on January 3, 2024, the company held the 12th meeting of the 3rd board of directors and the 9th meeting of the 3rd board of supervisors respectively to review and pass the “Proposal on Capital Increase to Wholly-owned Subsidiaries”, and agreed that the company would use savings to raise capital of 30.642,900 yuan and own capital of RMB 169.3571 million to increase capital for the wholly-owned subsidiary Shandong Linuo Pharmaceutical Co., Ltd. (“Linuo Pharmaceutical”). This matter did not constitute a related transaction, nor did it constitute a “Major Asset Reorganization Management Measures for Listed Companies” Of Major asset restructuring.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment